The Discounted Cash Flow (DCF) valuation of Tianda Pharmaceuticals Ltd (455.HK) is (0.63) HKD. With the latest stock price at 0.16 HKD, the upside of Tianda Pharmaceuticals Ltd based on DCF is -509.5%.
Based on the latest price of 0.16 HKD and our DCF valuation, Tianda Pharmaceuticals Ltd (455.HK) is a sell. selling 455.HK stocks now will result in a potential gain of 509.5%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 4.7% - 6.7% | 5.7% |
| Long-term Growth Rate | 3.0% - 4.4% | 3.7% |
| Fair Price | (4.62) - (0.36) | (0.63) |
| Upside | -3077.4% - -334.1% | -509.5% |